Healthtech Startups

Avixgen develops therapeutic treatments for ophthalmological diseases such as macular degeneration and dry eye, inflammatory conditions including atopic dermatitis, and an in-house drug delivery platform called ACP technology.

1 investor

FNCT Biotech is a biotech company based in South Korea. The page provides limited information about the company's specific products or services beyond its investment and program participation history.

1 investor

Exostemtech develops stem cell-derived exosome therapeutics and exosome platforms, including plant-derived exosomes, and offers research-use materials such as research stem cells and exosomes. The company operates in the biotechnology sector with a focus on exosome-based drug development.

1 investor

Endovision develops and manufactures medical devices including wound care, tissue regeneration, spinal surgery, sports medicine, gynecology, and laparoscopy products for hospitals and healthcare providers. The company, founded in 2013, focuses on domestic medical device innovation with capabilities in biotech products, 3D printing, and veterinary medical devices.

1 investor

NKMAX (엔케이젠바이오텍코리아 / NKGen Biotech Korea) is an immune cell therapy company focused on Natural Killer (NK) cells, developing NK-based immunotherapies, precision immune testing (NK cell activity tests), and immune health functional foods. Its products include NK cell activity diagnostic testing and the NK365 immune-support health supplement.

1 investor

Okchundang is a Korean herbal medicine (한의원) service provider operated by licensed Korean medicine doctors, offering distribution, herbal decoction (탕전) extraction and delivery systems for oriental medicine clinics. It also runs an hGMP-certified pharmaceutical arm supplying medicinal herbs and shares clinical academic information for practitioners.

1 investor

U2medtek develops SinusView, a near-infrared imaging device with AI algorithms for non-invasive, radiation-free diagnosis of sinusitis in clinical settings. The Class II certified medical device enables real-time visualization and automated analysis of sinus conditions for ENT and primary care clinicians.

1 investor

iMediTech (아이메디텍) develops, manufactures, and sells medical devices, including vascular grafts, vascular and cardiovascular stents, drug-eluting balloon catheters, and negative-pressure wound dressings. The South Korean company also distributes neurovascular devices such as TIGERTRIEVER and COMANECI.

1 investor

EHLBIO develops stem cell therapeutics and works in regenerative medicine, including an autologous adipose-derived stem cell treatment (ADSTEM) for conditions such as atopic dermatitis. The company is based in South Korea and its therapies are progressing through clinical trials with the Korean Ministry of Food and Drug Safety.

1 investor

GB SOFT develops AI software that measures vital signs — such as pulse, oxygen saturation, and stress levels — through contactless camera-based technology on smart devices. Its digital healthcare applications span wellness, industrial safety, autonomous mobility, and remote medical care.

1 investor

GLPharmTech is a pharmaceutical company that develops modified-release drug formulations, including Kabalin CR (pregabalin extended-release), for treating neuropathic pain conditions such as diabetic peripheral neuropathy and postherpetic neuralgia.

1 investor

Zincure is a biotech company developing treatments for brain disorders, focusing on acute conditions such as stroke and neurodegenerative diseases including ALS and multiple sclerosis. Founded in 2020, it conducts preclinical drug development in collaboration with hospitals and universities in Korea and the US.

1 investor

Kolon Pharmaceuticals develops pharmaceuticals and runs an oncology drug-discovery platform, using orthotopic transplant animal models and clinical translational research to identify anticancer targets, with a focus on pancreatic and ovarian cancer indications. The South Korean company co-develops new drugs with domestic and international biotech partners.

1 investor

Kolon TissueGene develops cell and gene therapies targeting musculoskeletal diseases and degenerative disorders. The company has built a proprietary platform over 20 years and aims to bring safe and effective treatments to improve pain and function for patients.

1 investor

Curacle develops first-in-class therapies aimed at restoring microvascular function in aging and chronic diseases, including small molecules via its SOLVADYS platform and biologics via its EAGLES platform. Its pipeline addresses conditions such as macular degeneration.

1 investor

Cureverse is a global biotech company that discovers novel small-molecule drugs based on its proprietary "Right Structure" concept, targeting intractable diseases including dementia, cancer, and inflammatory conditions. The company aims to provide sustainable therapeutic solutions with improved efficacy, safety, and drug-like properties for patients with difficult-to-treat neurological and systemic diseases.

1 investor

M2S develops virtual-reality-based medical devices for ophthalmology and neurology, including eye examination systems and equipment for diagnosing dizziness and brain lesions. The South Korean company's products are used by hospitals and clinics for vision, balance, and neurological testing.

1 investor

PeproMene Bio develops platform and products targeting BAFF-R, an innovative tumor antigen for treating B cell malignancies and autoimmune diseases. The company focuses on immune therapies to address tumor relapse caused by antigen loss in patients with unmet medical needs.

1 investor

FutureChem develops and manufactures radiopharmaceuticals for diagnostic imaging, particularly for detecting Alzheimer's disease, Parkinson's disease, and various cancers. The company operates GMP-compliant production facilities across multiple sites in South Korea to supply medical institutions.

1 investor

Promedius offers an AI-powered diagnostic tool that analyzes chest X-rays to detect osteoporosis and assess bone health for clinicians and patients. The platform uses deep learning algorithms to automatically identify at-risk patients and generate clinical reports integrated into existing hospital imaging systems.

1 investor

Igalphan is a Japanese research company focused on IgA antibodies, studying their potential for maintaining and improving health and preventing disease. The company works in collaboration with academic immunology research (referencing work from the University of Tokyo's immunology and infection control division).

1 investor

Innovacell searches globally for cell-based regenerative medicine candidates and develops and commercializes them into therapeutic products made from human cells, aiming to improve patients' health and quality of life. Its manufacturing technology originates from the GMP facility of Innovacell GmbH in Austria.

1 investor

Image One is a Japanese company that supplies medical equipment and healthcare services while also investing in local energy resources to support regional economies. Its business spans the healthcare industry and geospatial/GEO solutions, including cybersecurity products.

1 investor

Wellness Data operates JouleLife, a health coaching app paired with an original body composition scale and posture-support insole, helping users manage body shape and health metrics. It offers services to individuals as well as B2B health-management programs for companies and health insurance associations in Japan.

1 investor